Successful Use of Tralokinumab in a Pediatric Patient With STAT3 Hyper‐ IgE Syndrome Following Dupilumab‐Associated Conjunctivitis
Year: 2025
Type: article
Abstract: The authors declare no conflicts of interest. The data that support the findings of this study are openly available in Mendeley Data at: https://doi.org/10.17632/m86nv2w5nx.1.
DOI: 10.1111/ijd.70147
Institution: Hospital Universitario de Guadalajara
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4416143459
